Evidence map›Paper›PMID 26496982›Full record

ArticleCurrent vascular pharmacology2016

Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf.

Ibrahim Al-Zakwani, Wael Al-Mahmeed, Mohamed Arafah, Ali T Al-Hinai, Abdullah Shehab, Omer Al-Tamimi, Mahmoud Al-Awadhi, Shorook Al-Herz, Faisal Al-Anazi, Khalid Al-Nemer and 14 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Current vascular pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Patient journey for hypertension and dyslipidemia in Saudi Arabia: highlighting the evidence gaps.Archives of public health = Archives belges de sante publique · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Hypertension in Oman: Where Do We Stand?Oman medical journal · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 17 institutions in 9 countries.

Ibrahim Al-Zakwani
Wael Al-Mahmeed
Mohamed Arafah
Ali T Al-Hinai
Abdullah Shehab
Omer Al-Tamimi
Mahmoud Al-Awadhi
Shorook Al-Herz
Faisal Al-Anazi
Khalid Al-Nemer
Othman Metwally
Akram Al-Khadra
Mohammed Fakhry
Hossam Elghetany
Abdel R Medani
Afzal H Yusufali
Obaid Al-Jassim
Omar Al-Hallaq
Fahad O A S Baslaib
Haitham Amin
Raul D Santos
Khalid Al-Waili
Khamis Al-Hashmi
Khalid Al-RasadiDepartment of Biochemistry, Sultan Qaboos University Hospital, P.O. Box 38, Al-Khod, Muscat 123, Oman. k.alrasadi@gmail.com.
Sultan Qaboos University Hospital · OMDubai Health Authority · AEKing Fahd Hospital of the University · SASultan Qaboos University · OMAmerikan Hastanesi · TRAmiri Hospital · KWCleveland Clinic · USDubai Hospital · AEHamad Medical Corporation · QAIslamic University · BDKing Fahad Hospital Jeddah · SAKing Saud University · SAMinistry of Health · OMNational Guard Health Affairs · SASoliman Fakeeh Hospital · SAUnited Arab Emirates University · AEUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the control of cardiovascular disease (CVD) risk factors among patients with atherosclerotic cardiovascular disease (ASCVD) in the Centralized Pan-Middle East Survey on the undertreatment of hypercholesterolaemia (CEPHEUS) in the Arabian Gulf. Of the 4398 enrolled patients, overall mean age was 57 ± 11 years, 60% were males, 13% were smokers, 76% had diabetes, 71% had metabolic syndrome and 78% had very high ASCVD risk status. The proportion of subjects with body mass index <25 kgm2, HbA1c <7% (in diabetics), low-density lipoprotein cholesterol (LDL-C) <2.6 mmol/L (100 mg/dL) and <1.8 mmol/L (70 mg/dL) for high and very high ASCVD risk cohorts, respectively and controlled blood pressure (<140/90 mmHg) was 14, 26, 31% and 60%, respectively. Only 1.4% of the participants had all of their CVD risk factors controlled with significant differences among the countries (P < .001). CVD risk goal attainment rates were significantly lower in those with very high ASCVD risk compared with those with high ASCVD risk status (P < .001). Females were also, generally, less likely to attain goals when compared with males (P < .001).

Indexed as

AdultAgedCardiovascular DiseasesCross-Sectional StudiesDiabetes MellitusFemaleHumansHypercholesterolemiaHypertensionHypolipidemic AgentsMaleMetabolic SyndromeMiddle AgedMiddle EastObesityPrevalenceHypolipidemic Agents

Identifiers

PMID26496982
PMCPMC4997936
OpenAlexW2416887609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.